We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

181 hedge funds and large institutions have $256M invested in ImmunityBio in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 41 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $18.7M | Put options by funds: $10.9M

56% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 41

0.92% more ownership

Funds ownership: 8.95% → 9.86% (+0.92%)

6% less funds holding

Funds holding: 193 → 181 (-12)

28% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 32

35% less capital invested

Capital invested by funds: $391M → $256M (-$135M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
181
Holders Change
-12
Holders Change %
-6.22%
% of All Funds
2.6%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
64
Reduced
41
Closed
32
Calls
$18.7M
Puts
$10.9M
Net Calls
+$7.77M
Net Calls Change
+$18.9M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$14.2M
2
Morgan Stanley
Morgan Stanley
New York
+$7.77M
3
Bank of America
Bank of America
North Carolina
+$5.14M
4
Millennium Management
Millennium Management
New York
+$4.73M
5
State Street
State Street
Massachusetts
+$3.66M

Top Sellers

1
Jane Street
Jane Street
New York
-$7.5M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.59M
3
MG
Marex Group
-$1.38M
4
CAC
Cowen and Company
New York
-$1.26M
5
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$828K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
151
Arcadia Investment Management
Michigan
$3.71K +$4.63K +1,000 New
GRP
152
Global Retirement Partners
California
$3.46K – – –
GWM
153
Geneos Wealth Management
Colorado
$3.15K – – –
AW
154
Avion Wealth
Texas
$3K – – –
SSG
155
Summit Securities Group
New York
$3K +$4.15K +897 New
EWA
156
EverSource Wealth Advisors
Alabama
$2.69K – – –
AAP
157
Arax Advisory Partners
Colorado
$2.26K -$1.09K -236 -28%
WWM
158
Wolff Wiese Magana
California
$1.86K – – –
TCM
159
Tradewinds Capital Management
Washington
$1.86K +$2.31K +500 New
CTA
160
Colonial Trust Advisors
South Carolina
$1.58K – – –
SWM
161
Spire Wealth Management
Virginia
$1.57K – – –
Nisa Investment Advisors
162
Nisa Investment Advisors
Missouri
$1.49K +$398 +86 +27%
NA
163
NewEdge Advisors
Louisiana
$1.3K – – –
HT
164
Headlands Technologies
Illinois
$982 +$1.12K +242 +1,100%
SCM
165
Sterling Capital Management
North Carolina
$792 +$986 +213 New
MIA
166
MeadowBrook Investment Advisors
Michigan
$744 – – –
RIL
167
Rothschild Investment LLC
Illinois
$670 +$440 +95 +112%
ATC
168
Adirondack Trust Company
New York
$558 -$1.39K -300 -67%
GC
169
Gould Capital
Washington
$435 +$541 +117 New
SPIA
170
Steward Partners Investment Advisory
New York
$372 – – –
FFO
171
Fortitude Family Office
Arizona
$353 +$440 +95 New
HWM
172
HighMark Wealth Management
Minnesota
$149 – – –
SIC
173
SJS Investment Consulting
Ohio
$67 -$185 -40 -69%
DPW
174
DiNuzzo Private Wealth
Pennsylvania
$64 -$157 -34 -67%
JWA
175
JFS Wealth Advisors
Pennsylvania
$60 -$477 -103 -87%
5 6
7
8 9

IBRX Hedge Fund Activity: Q3 2024 in Review

181 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q3 2024, worth a combined $256M — down 35% from $391M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of IBRX and 23 opened new positions — a net loss of 9 holders — while 41 trimmed existing stakes and 64 added.

The largest buyer was Vanguard Group, adding an estimated $14.2M. The largest seller was Jane Street, cutting an estimated $7.5M.

  • 181 institutional investors held ImmunityBio (IBRX) as of Q3 2024, down from 193 in Q2 2024.
  • Funds reported $256M of ImmunityBio stock for Q3 2024, down 35% quarter-over-quarter.
  • 23 funds opened new ImmunityBio positions in Q3 2024 and 32 closed out, a net change of -9 holders.
  • The largest ImmunityBio buyer in Q3 2024 was Vanguard Group, an estimated $14.2M added.
  • The largest ImmunityBio seller in Q3 2024 was Jane Street, an estimated $7.5M sold.

Based on aggregated 13F filings for Q3 2024.